| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 10,216,000 | 13,885,000 | 10,363,000 | 13,714,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 10,216,000 | 13,885,000 | 10,363,000 | 13,714,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,008,000 | 16,009,000 | 5,341,000 | 12,389,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 208,000 | (2,124,000) | 5,022,000 | 1,325,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 208,000 | (2,124,000) | 5,022,000 | 1,325,000 | | Interest Expense | 1,168,000 | (3,573,000) | 3,573,000 |
-
| | Income Before Tax | (960,000) | 1,449,000 | 1,449,000 | 1,325,000 | | Income Tax Expense | (376,000) | 502,000 | 480,000 | 381,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (584,000) | 947,000 | 969,000 | 944,000 | | | Non-recurring Events | | Discontinued Operations | 36,000 | 38,000 | (339,000) | 2,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (548,000) | 985,000 | 630,000 | 946,000 | | Preferred Stock And Other Adjustments | (26,000) | (31,000) | (30,000) | (31,000) | | | Net Income Applicable To Common Shares | ($574,000) | $954,000 | $600,000 | $915,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
